Award
NIH Reporter #5U54CA233444-09
Pilot Project 6
Recipient
University of Florida
Award Amount
$172,445.00
Ceiling
$172,445.00
Awarded
September 14, 2026
Identifier
5U54CA233444-09
The project will evaluate novel compounds SYA013 and SYA014 in pancreatic cancer models, including drug-resistant models, organoids, and patient-derived xenografts, to investigate their anticancer activity and potential synergy with standard chemotherapy.
Description
Funding for research into the therapeutic potential of SYA013 and SYA014, alone and in combination with gemcitabine or fluorouracil, for pancreatic cancer.